In 2011, the National Institute for Health and Care Excellence (NICE) recommended that women presenting to their General Practitioner (GP) with symptoms of possible ovarian cancer in England, Wales, and Northern Ireland be tested for the serum biomarker cancer antigen 125 (CA125) [7]. The gene discussed is MUC16; the disease is ovarian cancer.